Life Sciences Tools & Services Companies By Net Asset

Net Asset
Net AssetEfficiencyMarket RiskExp Return
1TMO Thermo Fisher Scientific
97.32 B
 0.00 
 1.98 
(0.01)
2IQV IQVIA Holdings
26.9 B
 0.10 
 2.19 
 0.23 
3ICLR ICON PLC
16.88 B
 0.04 
 2.29 
 0.10 
4RVTY Revvity
12.39 B
 0.04 
 2.14 
 0.08 
5AVTR Avantor
12.11 B
(0.04)
 3.19 
(0.14)
6A Agilent Technologies
11.85 B
 0.11 
 2.01 
 0.23 
7BIO Bio Rad Laboratories
9.36 B
 0.04 
 2.33 
 0.09 
8CRL Charles River Laboratories
7.53 B
 0.22 
 3.09 
 0.69 
9ILMN Illumina
6.3 B
 0.21 
 2.31 
 0.49 
10BRKR Bruker
5.81 B
 0.09 
 2.61 
 0.23 
11QGEN Qiagen NV
5.69 B
 0.22 
 1.36 
 0.30 
12WAT Waters
4.55 B
(0.04)
 2.65 
(0.11)
13FTRE Fortrea Holdings
3.58 B
 0.00 
 5.66 
(0.01)
14MTD Mettler Toledo International
3.24 B
 0.16 
 2.21 
 0.36 
15SHC Sotera Health Co
3.07 B
 0.06 
 2.01 
 0.13 
16RGEN Repligen
2.83 B
(0.05)
 2.94 
(0.15)
17TECH Bio Techne Corp
2.7 B
 0.07 
 2.50 
 0.18 
18MEDP Medpace Holdings
2.1 B
 0.07 
 2.21 
 0.15 
19AZTA Azenta Inc
2.1 B
 0.13 
 2.91 
 0.39 
20PACB Pacific Biosciences of
1.26 B
 0.08 
 5.49 
 0.43 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund. Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.